The Efficacy and Safety of Nafamostat Mesylate in the Treatment of COVID-19: A Meta-Analysis
Description
Nafamostat mesylate, a synthetic serine protease inhibitor, has demonstrated early antiviral activity against SARS-CoV-2 and anticoagulant properties that may be beneficial in COVID-19. We conducted a meta-analysis evaluating the efficacy and safety
